Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Thrombin Receptor Activator Peptide 6, CAS 141136-83-6

Thrombin Receptor Activator Peptide 6, CAS 141136-83-6 US$514.80 Excluding tax and shipping fees In stock Description About Thrombin Receptor Activator Peptide 6, CAS 141136-83-6 Thrombin Receptor Activator Peptide 6 - (CAS 141136-83-6) (TRAP-6) is a peptide f

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Thrombin Receptor Activator Peptide 6, CAS 141136-83-6

US$514.80

Excluding tax and shipping fees

In stock

Description

About Thrombin Receptor Activator Peptide 6, CAS 141136-83-6

Thrombin Receptor Activator Peptide 6 - (CAS 141136-83-6) (TRAP-6) is a peptide for cancer research. The Thrombin Receptor Activator Peptide 6 - (CAS 141136-83-6), H-SFLLRN-OH from JPT is produced under strict quality control and quality management.

Thrombin Receptor Activator Peptide 6, CAS 141136-83-6 - Specifications

Peptide sequence: H-SFLLRN-OH

Amount: 5 mg

Purity: >95% (HPLC-MS)

Delivery Format: Freeze-dried in plastic vial

Chemical formula: C34H56N10O9

MW (average): 748.88

Application(s):

Condition(s)/Topic(s): Platelet aggregation. Platelet function testing

Standard Delivery Time: approx. 3 weeks

CAS: 141136-83-6

Non-RGD Cancer Peptides from JPT

Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.

Benefits of JPT’s Non-RGD Cancer Peptides

Each peptide quality controlled and guaranteed for identity and purity

CoA and HPLC-MS data available

High batch-to-batch consistency

Synthesis protocols designed to avoid toxic contaminants and side products

Provision of freeze dried aliquots for enhanced stability

Proven track record for applications in clinical studies

References

References for Thrombin Receptor Activator Peptide 6, CAS 141136-83-6

ReferencesRead References with Peptides made by JPT

Documentation

Documentation for Thrombin Receptor Activator Peptide 6, CAS 141136-83-6

Thrombin-Receptor-Activator-Peptide-6-CAS-141136-.pdf

Properties

Properties of Thrombin Receptor Activator Peptide 6, CAS 141136-83-6

5 mg

Single Peptide

Freeze-dried in plastic vial

Human

>95% (HPLC-MS)

No

Further Information to Thrombin Receptor Activator Peptide 6, CAS 141136-83-6

Values

H-SFLLRN-OH

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →